Table 3.
Lipids (mmol/L) |
Male |
Female |
||
Patients (n = 31) | Controls (n = 20) | Patients (n = 38) | Controls (n = 17) | |
TG | 0.85 ± 0.50 | 0.53 ± 0.22 | 1.10 ± 0.30 | 0.72 ± 0.57 |
TC | 3.05 ± 0.44 | 0.41 ± 0.57 | 3.23 ± 0.85 | 3.87 ± 0.63 |
LDL-C | 1.86 ± 0.68 | 2.71 ± 0.49 | 1.89 ± 0.86 | 2.20 ± 0.56 |
VLDL-C | 0.40 ± 0.24 | 0.25 ± 0.10 | 0.52 ± 0.14 | 0.35 ± 0.17 |
HDL-C | 0.94 ± 0.33 | 1.21 ± 0.28 | 0.82 ± 0.27b | 1.33 ± 0.19 |
HDL2-C | 0.52 ± 0.22 | 0.69 ± 0.16 | 0.46 ± 0.15b | 0.77 ± 0.10 |
HDL3-C | 0.42 ± 0.12 | 0.52 ± 0.13 | 0.36 ± 0.12b | 0.57 ± 0.10 |
P < 0.01, vs controls, F test.